-
ADIL Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Adial Pharmaceuticals (ADIL)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.20 mm | 5.20 mm | 5.20 mm | 5.20 mm | 5.20 mm | 5.20 mm |
Cash burn (monthly) | (no burn) | (no burn) | 737.16 k | 995.87 k | (no burn) | 350.73 k |
Cash used (since last report) | n/a | n/a | 2.05 mm | 2.77 mm | n/a | 977.23 k |
Cash remaining | n/a | n/a | 3.15 mm | 2.43 mm | n/a | 4.23 mm |
Runway (months of cash) | n/a | n/a | 4.3 | 2.4 | n/a | 12.1 |
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 2 |
Closed positions | 10 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 30.77 mm |
Total shares | 699.10 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Schuyler Kevin | 673.60 k | $1.47 mm |
Citadel Advisors | 24.75 k | $28.46 mm |
BAC Bank of America | 689.00 | $792.00 k |
MS Morgan Stanley | 39.00 | $45.00 k |
RY Royal Bank of Canada | 19.00 | $0.00 |
Qube Research & Technologies | 8.00 | $10.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Dec 24 | Cary J Claiborne | Stock Option Common Stock | Grant | Acquire A | No | No | 1.15 | 350,000 | 402.50 k | 350,000 |
16 Nov 24 | Vinay Shah | Stock Option Common Stock | Grant | Acquire A | No | No | 1.06 | 40,000 | 42.40 k | 40,000 |
25 Mar 24 | Joseph Truluck | Stock Option Common Stock | Grant | Acquire A | No | No | 1.35 | 25,000 | 33.75 k | 25,000 |
25 Mar 24 | Cary J Claiborne | Stock Option Common Stock | Grant | Acquire A | No | No | 1.35 | 60,000 | 81.00 k | 60,000 |